Neptune Technologies & Bioressources Inc., Re-Enforces the South East Asian Market
Tuesday, August 30 2005

Neptune Technologies & Bioressources Inc., Re-Enforces the South East Asian Market

Laval, Quebec CANADA, August 30, 2005 - Neptune Technologies & Bioresources Inc. (NTB - TSX Venture) active in the field of high value-added natural product extraction from marine biomasses, such as krill, is pleased to announce that Neptune Krill Oil is re-enforcing its market penetration in South East Asia with three new distributors.

Dr. Gang He, M.D., M.Sc., MBA, Director, International Sales & Marketing at Neptune Technologies & Bioressources Inc. recently concluded distributor agreements resulting directly from the very successful Natural Product Expo Asia in Hong-Kong, Mr. He commented: Neptune signed three distribution agreements for the South East Asia market, which includes Taiwan, Singapore, Malaysia, Indonesia and the Philippines, which are presently launching pure NKO™ supplements through their respective channels. These agreements are a tremendous opportunity for NKOand its success”.

“The market covered by our new distributors represents 12 times the size of Canada’s population. These distributors, which are newly signed by Neptune, have successfully penetrated their market for their knowledge on the importance of marine Omega products, such as NKO™, and the role they play for our wellness. It is a very promising start” added Dr. Gang He.

This press release is available on the Company's on-line Investor Relations site for investor commentary, feedback and questions. Investors are invited to visit http://www.agoracom.com/ and select the Neptune Technologies Information and Contact Forum, or link directly to it at http://www.agoracom.com/nonmemforum/main.asp?topic=neptune+technologies&tr;

Investors are also invited to e-mail any questions regarding the Company directly to This e-mail address is being protected from spambots, you need JavaScript enabled to view it Potential investors may also use this address to request being added to the Neptune Technologies investor e-mail list.

About Neptune Technologies & Bioressources. https://www.neptunebiotech.com/

Neptune Technologies & Bioressources Inc. develops and exploits marine biomasses with its patented extraction process Neptune OceanExtract™ utilizing marine biomasses, such as krill, and due to its technologies, Neptune Technologies & Bioressources Inc., is strategically well positioned in the $182 billion global nutrition market (Nutrition Business Journal, Oct/Nov 2004) based on the health and wellness concepts, markets in which natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research.

Neither NASDAQ nor TSX venture exchange accepts responsibility for the adequacy or accuracy of this press release.
Neptune Technologies and Acasti Pharma Contact:
Neptune Technologies & Bioressources Inc.
Acasti Pharma Inc.
Toni Rinow, Ph.D., MBA
Corporate Development & Investor Relations
(450) 687-2262
This e-mail address is being protected from spambots, you need JavaScript enabled to view it
# # #
Statements in this press release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and Canadian securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of the Company to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "expects," "intends," "anticipates," "will," or "plans" to be uncertain and forward-looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the Company's reports filed with the Securities and Exchange Commission and the Canadian securities commissions.
 

We communicate

NTB (TSX) CAN$ 1.93 +0.03
NEPT (NASDAQ) US$ 1.898 +0.068
 

press releases

Investor Relations Contact NEPTUNE TECHNOLOGIES & BIORESSOURCES